Return to homepagePandemic Pact

to develop a repository of essential diagnostics reagents, and to evaluate diagnostics tools for the novel SARS-CoV-2 virus

Grant number: INV-016821

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2020

  • Known Financial Commitments (USD)

    $4,271,768

  • Funder

    Gates Foundation

  • Research Location

    United States of America

  • Lead Research Institution

    PATH

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Diagnostics

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

N/A

4 Publications linked via Europe PMC

Last Updated:4 days ago

View all publications at Europe PMC

Differential Severe Acute Respiratory Syndrome Coronavirus 2-Specific Humoral Response in Inactivated Virus-Vaccinated, Convalescent, and Breakthrough-Infected Subjects.

From biorepositories to data repositories: Open-access resources accelerate early R&D and validation of equitable diagnostic tools.

A Reagent and Virus Benchmarking Panel for a Uniform Analytical Performance Assessment of N Antigen-Based Diagnostic Tests for COVID-19.

Screening Antibodies Raised against the Spike Glycoprotein of SARS-CoV-2 to Support the Development of Rapid Antigen Assays.